Activity of Corallopyronin A Against ESKAPEE Pathogens: Potential and Translational Implications

Jennifer M Colquhoun1, Kara W Marshall1, Miriam Grosse2,3

  • 1Research Service, Atlanta VA Medical Center, Decatur, GA 30033, USA.

Summary

Corallopyronin A (CorA) shows selective activity against Acinetobacter baumannii, including rifampin-resistant strains. Its potential therapeutic utility is highlighted for biofilm infections and other applications despite serum binding challenges.